@prefix foaf:	<http://xmlns.com/foaf/0.1/> .
@prefix wikipedia-en:	<http://en.wikipedia.org/wiki/> .
@prefix dbr:	<http://dbpedia.org/resource/> .
wikipedia-en:Avasimibe	foaf:primaryTopic	dbr:Avasimibe .
@prefix rdf:	<http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix ns4:	<http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#> .
dbr:Avasimibe	rdf:type	ns4:ChemicalObject .
@prefix owl:	<http://www.w3.org/2002/07/owl#> .
dbr:Avasimibe	rdf:type	owl:Thing .
@prefix dbo:	<http://dbpedia.org/ontology/> .
dbr:Avasimibe	rdf:type	dbo:Drug ,
		dbo:ChemicalSubstance .
@prefix wikidata:	<http://www.wikidata.org/entity/> .
dbr:Avasimibe	rdf:type	wikidata:Q8386 .
@prefix dbpedia-global:	<https://global.dbpedia.org/id/> .
dbr:Avasimibe	owl:sameAs	dbpedia-global:GQowU ,
		dbr:Avasimibe ,
		wikidata:Q112114878 .
@prefix rdfs:	<http://www.w3.org/2000/01/rdf-schema#> .
dbr:Avasimibe	rdfs:label	"Avasimibe"@en .
@prefix dct:	<http://purl.org/dc/terms/> .
@prefix dbc:	<http://dbpedia.org/resource/Category:> .
dbr:Avasimibe	dct:subject	dbc:Pfizer ,
		dbc:Lipid-lowering_agents ,
		dbc:Terpenes_and_terpenoids ,
		dbc:Sulfamate_esters ;
	foaf:depiction	<http://commons.wikimedia.org/wiki/Special:FilePath/Avasimibe.svg> .
@prefix prov:	<http://www.w3.org/ns/prov#> .
dbr:Avasimibe	prov:wasDerivedFrom	<http://en.wikipedia.org/wiki/Avasimibe?oldid=1312020404&ns=0> ;
	foaf:isPrimaryTopicOf	wikipedia-en:Avasimibe .
@prefix dbp:	<http://dbpedia.org/property/> .
dbr:Avasimibe	dbp:stdinchi	1 ;
	dbo:fdaUniiCode	"28LQ20T5RC" ;
	dbp:smiles	"CCC1=COSNCCC2=CCC"@en ;
	dbo:casNumber	"166518-60-1" ;
	dbp:legalStatus	"Investigational"@en ;
	dbp:o	4 ;
	dbp:stdinchikey	"PTQXTEKSNBVPQJ-UHFFFAOYSA-N"@en ;
	dbp:chemspiderid	145759 ;
	dbp:iupacName	"[2,6-diphenyl] N-[2-[2,4,6-triphenyl]acetyl]sulfamate"@en ;
	dbp:atcPrefix	"10.0"^^<http://dbpedia.org/datatype/nicaraguanC\u00F3rdoba> ;
	dbp:c	29 ;
	dbo:pubchem	"166558" ;
	dbp:h	43 ;
	dbp:casNumber	166518 ;
	dbp:routesOfAdministration	"Oral"@en ;
	dbp:pubchem	166558 ;
	dbp:unii	28 ;
	dbp:atcSuffix	"AX"@en ;
	dbp:chebi	177719 ;
	dbp:chembl	101309 ;
	dbp:drugbank	6442 .
@prefix dbd:	<http://dbpedia.org/datatype/> .
dbr:Avasimibe	dbp:eliminationHalfLife	"-86400.0"^^dbd:second ;
	dbp:kegg	"D03012"@en ;
	dbo:chEBI	"177719" ;
	dbo:chEMBL	"101309" ;
	dbo:drugbank	"06442" ;
	dbo:kegg	"D03012" ;
	dbp:metabolism	"Hepatic"@en ;
	dbp:synonyms	26 ;
	dbp:s	1 ;
	dbo:thumbnail	<http://commons.wikimedia.org/wiki/Special:FilePath/Avasimibe.svg?width=300> ;
	dbp:n	1 ;
	dbo:wikiPageWikiLink	dbr:Hyperlipidemia ,
		dbc:Hypolipidemic_agents ,
		dbc:Terpenes_and_terpenoids ,
		dbc:Sulfamates ,
		dbr:SOAT1 ,
		dbr:Atherosclerosis ,
		dbr:Cholesterol ,
		dbr:Drug_interaction ,
		dbr:Enzyme_inhibitor ,
		dbr:Rifampin ,
		dbr:CYP2C19 ,
		dbr:CYP1A2 ,
		dbr:Rat ,
		dbr:Rational_drug_design ,
		dbr:LDL_cholesterol ,
		dbr:Drug_repurposing ,
		dbr:Pregnane_X_receptor ,
		dbr:Virulence ,
		dbr:Metabolism ,
		dbr:Drug_discovery ,
		dbr:Sterol_O-acyltransferase ,
		<http://dbpedia.org/resource/Area_under_the_curve_(pharmacokinetics)> ,
		dbr:CYP2C9 ,
		<http://dbpedia.org/resource/Cmax_(pharmacology)> ,
		dbr:Liver ,
		dbc:Pfizer ,
		dbr:Retrosynthetic_analysis ,
		dbr:Isoenzyme ,
		dbr:Catabolism ,
		dbr:Cytochrome_P450 ,
		dbr:Bacteria ,
		dbr:Antitumor ,
		dbr:International_Nonproprietary_Name ,
		dbr:Pfizer ,
		dbr:P-glycoprotein ,
		dbr:Lipid-lowering_agent ,
		dbr:Parke-Davis ,
		dbr:SOAT2 ,
		dbr:Enzyme ,
		dbr:Enzyme_inducer ,
		dbr:Lipophilic ,
		dbr:CYP3A4 .
@prefix dbt:	<http://dbpedia.org/resource/Template:> .
dbr:Avasimibe	dbp:wikiPageUsesTemplate	dbt:Short_description ,
		dbt:Infobox_drug ,
		dbt:Reflist ,
		dbt:As_of ;
	dbp:excretion	"Fecal , renal"@en .
<http://dbpedia.org/resource/List_of_drugs:_As\u2013Az>	dbo:wikiPageWikiLink	dbr:Avasimibe .